Anorexia Nervosa Clinical Trial
Official title:
Evaluation of CARdiac Morphological and Functional Abnormalities by Echocardiography and Magnetic Resonance Imaging in Malnourished Patients Suffering From Anorexia Nervosa
Anorexia nervosa is an eating disorder occurring in adolescent females, characterized by
voluntary dietary restriction, intense fear of gaining weight, and disturbed body image
perception. Anorexia nervosa is characterized by the potential severity of its prognosis.
While complete remission occurs in about 50% of cases, up to 20% of patients will develop a
chronic relapsing form that leads to social disintegration. Moreover, anorexia nervosa has
the highest mortality rate among psychiatric diseases with a risk of death of up to 10%. 30%
of deaths in anorexia nervosa are attributed to cardiac complications remaining
insufficiently described, and their screening at a preclinical stage is still poorly
codified. Echocardiography findings show reduced left ventricular mass, pericardial effusion
or mitral valve prolapse ; in addition, systolic function appears to be preserved whereas a
global diastolic dysfunction, estimated with trans-mitral flow and global longitudinal
strain. While the interest of cardiac echography has been well established, only one study
used MRI as a means of cardiac evaluation in anorexia nervosa: interestingly, local
myocardial fibrosis is pointed and could potentially contribute to cardiac rhythm disorders.
No study has yet used T1-Mapping MRI to evaluate if diffuse myocardial fibrosis is prevalent
in this population group.
The investigators conduct a transversal, observational, monocentric study whereby
malnourished patients with anorexia nervosa and age- and sex- matched, normal weight, healthy
volunteers will undergo a gadolinium-enhanced cardiac MRI. The primary objective of this
study is to evaluate and compare the frequency of cardiac fibrosis in those populations.
Other cardiac MRI parameters will be described and compared as secondary objectives.
Moreover, non-cardiac parameters evaluated by MRI such as adipose tissue distribution in
anorexia nervosa patients compared with controls.
In addition, patients with anorexia nervosa, a clinical, morphological and biological
evaluation, including anthropometric parameters, biphotonic absorptiometry, resting
electrocardiogram, cardiac echography and classical biological markers of malnutrition, will
be done.
Anorexia nervosa is an eating disorder occurring most frequently in adolescent females,
characterized by 1/ voluntary dietary restriction, leading to lower than normal body weight
and, often, loss of considerable amount of weight and, thereby, malnutrition, 2/ intense fear
of gaining weight, even when the individual is already underweight, starved or malnourished
and 3/ disturbed body image perception, including extreme emphasis on the appearance.
Anorexia nervosa is characterized by the potential severity of its prognosis. While complete
remission occurs in about 50% of cases, up to 20% of patients will develop a chronic
relapsing form that leads to social disintegration. Moreover, anorexia nervosa has the
highest mortality rate among psychiatric diseases with a risk of death of up to 10%
(including suicide and clinical complications of severe malnutrition). If approximatively 30%
of deaths in anorexia nervosa are attributed to cardiac complications, the nature and the
frequency of such complications remain insufficiently described, and their screening at a
preclinical stage is still poorly codified. Echocardiography findings are well documented and
include reduced left ventricular mass, pericardial effusion (in 22 to 35% of cases), or
mitral valve prolapse (in up to 35% of cases); in addition, systolic function, evaluated by
the ejection fraction appears to be preserved whereas a global diastolic dysfunction,
estimated with trans-mitral flow and global longitudinal strain, is reported. While the
interest of cardiac echography has been well established, only one study used MRI (magnetic
resonance imaging) as a means of cardiac evaluation in anorexia nervosa: interestingly, this
study found local myocardial fibrosis in nearly 25% of patients with anorexia nervosa, which
could potentially contribute to cardiac rhythm disorders. That said, no study has yet used
T1-Mapping MRI to evaluate if diffuse myocardial fibrosis is prevalent in this population
group.
The investigators aim to conduct a transversal, observational, monocentric study whereby
malnourished patients with anorexia nervosa (n = 38) and age- and sex- matched, normal
weight, healthy volunteers (n = 38) will undergo a gadolinium-enhanced cardiac MRI. The
primary objective of this study is to evaluate and compare the frequency of cardiac fibrosis
in those populations using cardiac MRI. Other morphological and functional cardiac MRI
parameters will be described and compared as secondary objectives: local myocardial fibrosis
using enhanced MRI; myocardial and left ventricular mass; myocardial triglyceride
quantification using Proton spectroscopy; cardiac high-energy metabolism using Phosphore-31
spectroscopy. Moreover, non-cardiac parameters evaluated by MRI such as adipose tissue
distribution (visceral fat, liver fat, bone marrow fat) in anorexia nervosa patients compared
with controls.
In addition, patients with anorexia nervosa, a clinical, morphological and biological
evaluation, including anthropometric parameters, biphotonic absorptiometry, resting
electrocardiogram, cardiac echography and classical biological markers of malnutrition, will
be done. Multivariate analysis will then be used to identify possible correlating factors
between cardiac MRI findings and clinical, morphological and biological parameters in
malnourished patients with anorexia nervosa, so as to shed light on possible new risk
stratification models or predictive tools for cardiac complications that could be later
evaluated by appropriate studies.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05531604 -
Appetitive Conditioning in Anorexia Nervosa
|
||
Enrolling by invitation |
NCT04174703 -
Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing
|
N/A | |
Active, not recruiting |
NCT04883554 -
Impact of an Olfactory Sensory Therapeutic Group for Adolescent Patients With Restrictive Anorexia Nervosa , Pilot Study
|
N/A | |
Recruiting |
NCT04213820 -
TMS and Body Image Treatment for Anorexia Nervosa
|
N/A | |
Completed |
NCT03414112 -
The Impact of Oxytocin on the Neurobiology of Anorexia Nervosa
|
Early Phase 1 | |
Recruiting |
NCT06144905 -
Norwegian Microbiota Study in Anorexia Nervosa
|
||
Recruiting |
NCT05803707 -
Home-based Adapted Physical Activity in Anorexia Nervosa: a Feasibility Pilot Study
|
N/A | |
Recruiting |
NCT05682417 -
Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa
|
N/A | |
Not yet recruiting |
NCT06380257 -
Anorexia Nervosa and Brain in Adolescence
|
||
Not yet recruiting |
NCT04804800 -
Virtual Reality Place in the Management of Body Dysmorphia Disorders in Anorexia Nervosa
|
N/A | |
Completed |
NCT02745067 -
Effectiveness of Enhanced Cognitive Behavioral Therapy (CBT-E) in the Treatment of Anorexia Nervosa
|
N/A | |
Completed |
NCT02382055 -
Changing Habits in Anorexia Nervosa: Novel Treatment Development
|
N/A | |
Completed |
NCT03075371 -
Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa
|
N/A | |
Terminated |
NCT02240797 -
Kappa Opioid Receptor Imaging in Anorexia
|
N/A | |
Unknown status |
NCT01761942 -
Fatty Acids Omega -3 Diet Supplementation Efficiency and Safety Evaluation in Anorexia Nervosa
|
Phase 2 | |
Completed |
NCT03144986 -
Insula-coil Deep TMS for Treatment Resistant Anorexia Nervosa
|
N/A | |
Completed |
NCT01579682 -
Adaptive Family Treatment for Adolescent Anorexia Nervosa
|
N/A | |
Completed |
NCT02551445 -
A fMRI Pilot Study of the Effects of Meal-support in Eating Disorders.
|
N/A | |
Completed |
NCT00946816 -
The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity
|
N/A | |
Recruiting |
NCT00942929 -
Lung Function Tests in Adolescents With Anorexia Nervosa
|
N/A |